BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12706882)

  • 1. Aberrant processing of Fas transcripts in adult T-cell leukemia: a possible role in tumor cell survival.
    Tawara M; Maeda T; Yamada Y; Harasawa H; Tsuruda K; Sugahara K; Moriuchi R; Tomonaga M; Kamihira S
    Cancer Lett; 2003 Apr; 193(2):235-42. PubMed ID: 12706882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepant expression of membrane and soluble isoforms of Fas (CD95/APO-1) in adult T-cell leukaemia: soluble Fas isoform is an independent risk factor for prognosis.
    Kamihira S; Yamada Y; Tomonaga M; Sugahara K; Tsuruda K
    Br J Haematol; 1999 Dec; 107(4):851-60. PubMed ID: 10606894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines.
    Sugahara K; Yamada Y; Hiragata Y; Matsuo Y; Tsuruda K; Tomonaga M; Maeda T; Atogami S; Tsukasaki K; Kamihira S
    Int J Cancer; 1997 Jul; 72(1):128-32. PubMed ID: 9212233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The conformational alteration of the mutated extracellular domain of Fas in an adult T cell leukemia cell line.
    Maeda T; Nakayama S; Yamada Y; Sugahara K; Isomoto H; Tawara M; Yamasaki R; Onimaru Y; Matsushita T; Ohzono Y; Kamihira S
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1251-6. PubMed ID: 12207908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas gene mutation in the progression of adult T cell leukemia.
    Maeda T; Yamada Y; Moriuchi R; Sugahara K; Tsuruda K; Joh T; Atogami S; Tsukasaki K; Tomonaga M; Kamihira S
    J Exp Med; 1999 Apr; 189(7):1063-71. PubMed ID: 10190897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible attenuation of fas-mediated signaling by dominant expression of caspase-8 aberrant isoform in adult T-cell leukemia cells.
    Sugahara K; Hayashi T; Dateki N; Hirakata Y; Harasawa H; Tomonaga M; Yamada Y; Kamihira S
    Int J Hematol; 2002 Jul; 76(1):50-4. PubMed ID: 12138895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production.
    Yamada Y; Sugahara K; Tsuruda K; Nohda K; Hata T; Maeda T; Honda M; Tawara M; Hayashibara T; Joh T; Tomonaga M; Miyazaki Y; Kamihira S
    Cancer Lett; 1999 Dec; 147(1-2):215-9. PubMed ID: 10660109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias.
    Kamihira S; Yamada Y; Hirakata Y; Tsuruda K; Sugahara K; Tomonaga M; Maeda T; Tsukasaki K; Atogami S; Kobayashi N
    Br J Haematol; 1997 Dec; 99(4):858-65. PubMed ID: 9432034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants.
    Wood CM; Goodman PA; Vassilev AO; Uckun FM
    Eur J Haematol; 2003 Mar; 70(3):156-71. PubMed ID: 12605660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Fas (APO-1/CD95) isoform in adult T-cell leukemia.
    Kamihira S; Yamada Y
    Leuk Lymphoma; 2001 Mar; 41(1-2):169-76. PubMed ID: 11342370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.
    Shen L; Liang AC; Lu L; Au WY; Kwong YL; Liang RH; Srivastava G
    Am J Pathol; 2002 Dec; 161(6):2123-31. PubMed ID: 12466128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expressed Fas improves the apoptosis of malignant T-cells in vitro and vivo.
    Li L; Zhang R; Chen Z; Xue S; Wang X; Ruan C
    Mol Biol Rep; 2011 Nov; 38(8):5371-7. PubMed ID: 21390503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing.
    Cascino I; Fiucci G; Papoff G; Ruberti G
    J Immunol; 1995 Mar; 154(6):2706-13. PubMed ID: 7533181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of functional Fas antigen on adult T-cell leukemia.
    Kotani T; Aratake Y; Kondo S; Tamura K; Ohtaki S
    Leuk Res; 1994 Apr; 18(4):305-10. PubMed ID: 7513372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new alternative splice variant of the mouse Fas antigen with a deletion in the N-terminal portion of the extracellular domain.
    Nakajima T; Ichii S; Furuyama J; Tamaoki T; Hashimoto T
    Life Sci; 1996; 58(9):761-8. PubMed ID: 8632723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization.
    Murata K; Hayashibara T; Sugahara K; Uemura A; Yamaguchi T; Harasawa H; Hasegawa H; Tsuruda K; Okazaki T; Koji T; Miyanishi T; Yamada Y; Kamihira S
    J Virol; 2006 Mar; 80(5):2495-505. PubMed ID: 16474156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternatively spliced transcripts of Fas mRNAs in feline lymphoid cells.
    Mizuno T; Baba K; Goto Y; Masuda K; Ohno K; Tsujimoto H
    Eur J Immunogenet; 2004 Aug; 31(4):159-66. PubMed ID: 15265020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia.
    Farre L; Bittencourt AL; Silva-Santos G; Almeida A; Silva AC; Decanine D; Soares GM; Alcantara LC; Van Dooren S; Galvão-Castro B; Vandamme AM; Van Weyenbergh J
    J Leukoc Biol; 2008 Jan; 83(1):220-2. PubMed ID: 17962369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn.
    Chu JL; Drappa J; Parnassa A; Elkon KB
    J Exp Med; 1993 Aug; 178(2):723-30. PubMed ID: 7688033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis.
    Kamihira S; Yamada Y; Hirakata Y; Tomonaga M; Sugahara K; Hayashi T; Dateki N; Harasawa H; Nakayama K
    Br J Haematol; 2001 Jul; 114(1):63-9. PubMed ID: 11472346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.